Diabetologia·1 OctComparative hepatic effectiveness of empagliflozin vs dapagliflozin among individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver diseaseCohort study of 265,098 peopleEmpagliflozinPaper
ADA Scientific Sessions 2026 Abstract·5 JunSecond-Line Antidiabetic Exposure in Early Pregnancy and Risk of Spontaneous Abortion: A Nationwide Cohort StudyStudy in peoplePopulationsPaper